Organ Size Control Is Dominant over Rb Family Inactivation to Restrict Proliferation In Vivo  by Ehmer, Ursula et al.
Cell Reports
ReportOrgan Size Control Is Dominant
over Rb Family Inactivation
to Restrict Proliferation In Vivo
Ursula Ehmer,1,2,3 Anne-Flore Zmoos,1,2 Raymond K. Auerbach,1,2 Dedeepya Vaka,1,2 Atul J. Butte,1,2 Mark A. Kay,1,2
and Julien Sage1,2,*
1Department of Pediatrics
2Department of Genetics
Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA
3Present address: Klinikum rechts der Isar, Technische Universita¨t Mu¨nchen, II. Medizinische Klinik und Poliklinik, Ismaninger Strasse 22,
81675 Munich, Germany
*Correspondence: julsage@stanford.edu
http://dx.doi.org/10.1016/j.celrep.2014.06.025
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARY
In mammals, a cell’s decision to divide is thought
to be under the control of the Rb/E2F pathway. We
previously found that inactivation of the Rb family
of cell cycle inhibitors (Rb, p107, and p130) in quies-
cent liver progenitors leads to uncontrolled division
and cancer initiation. Here, we show that, in contrast,
deletion of the entire Rb gene family in mature hepa-
tocytes is not sufficient for their long-term prolifera-
tion. The cell cycle block in Rb family mutant hepato-
cytes is independent of the Arf/p53/p21 checkpoint
but can be abrogated upon decreasing liver size. At
themolecular level, we identify YAP, a transcriptional
regulator involved in organ size control, as a factor
required for the sustained expression of cell cycle
genes in hepatocytes. These experiments identify a
higher level of regulation of the cell cycle in vivo in
which signals regulating organ size are dominant
regulators of the core cell cycle machinery.INTRODUCTION
A cell’s decision to continue cycling, exit the cell cycle, or start
proliferating is paramount to embryonic development, homeo-
stasis in the adult organism, and cancer development. Extra-
and intracellular signals that govern the cell cycle are integrated
and relayed by the Rb pathway. Under cytostatic conditions,
Rb and its family members p107 and p130 block cell cycle
progression in G0/G1, in large part by interacting with E2F tran-
scription factors to repress the expression of cell cycle genes.
Phosphorylation by Cyclin/Cdk complexes in response to mito-
gens functionally inactivates Rb family members and results in
increased E2F activity and cell cycle progression. Rb pathway
members have also been involved in many other biological pro-
cesses, including differentiation, survival, chromosomal stability,
metabolism, and senescence. Alterations in members of the Rbpathway are found in the vast majority of human tumors, under-
scoring the central role of this pathway in the biology of mam-
malian cells and the maintenance of homeostasis (reviewed in
Dick and Rubin, 2013; Manning and Dyson, 2012; Nicolay and
Dyson, 2013).
A notable feature of the cell cycle machinery in mammals is a
high level of functional redundancy. Accordingly, while overex-
pression of one Rb family member is often sufficient to promote
cell cycle arrest (or cell death), inactivation of only one family
protein often results in limited long-term cell cycle defects.
For instance, acute loss of Rb function can only partly abrogate
quiescence, in part because of a compensatory transcriptional
upregulation of p107 (Sage et al., 2003). In contrast, combined
inactivation of Rb family members leads to increased prolife-
ration and, eventually, complete loss of the G1 checkpoint in
culture (see for example Dannenberg et al., 2000; Sage et al.,
2000). Similarly, while Rb mutant mice have a limited tumor
spectrum, inactivation of the Rb family results in long-term
ectopic proliferation and is often followed by neoplastic trans-
formation in mice (see for example Dannenberg et al., 2004;
McEvoy et al., 2011; Robanus-Maandag et al., 1998; Viatour
et al., 2011).
The liver of mammals has a remarkable regenerative ability
compared to other adult organs and tissues. Hepatocytes
are capable of proliferation and growth in response to liver
damage, including partial hepatectomy. Under certain condi-
tions, liver progenitor cells with the capacity of generating
both hepatocytes and bile duct cells are believed to contribute
to regeneration in the adult liver (reviewed in Duncan et al.,
2009). Thus, with a large number of cells having retained the
capacity to divide, the adult liver is a system of choice to
explore the mechanisms regulating cell cycle progression
in vivo.
Here, we investigated the consequences of in vivo abrogation
of the Rb pathway in the liver of adult mice. We found that the
control of cell cycle is different in hepatocytes and their progen-
itors and identified interactions between the Rb/E2F pathway
and organ size sensing mechanisms that are critical for the
long-term proliferative potential of hepatocytes in vivo.Cell Reports 8, 371–381, July 24, 2014 ª2014 The Authors 371
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Figure 1. Rb Pathway Inactivation Leads to Transient Cell Cycle Entry in Hepatocytes
(A) Schematic representation of the Sleeping Beauty (SB) transposon-CreER system. ApoE.HCR.hAAT drives the expression of CreERT2 specifically in hepa-
tocytes.
(B and C) Acute Cre-mediated Rb gene family deletion in adult hepatocytes leads to cell cycle entry followed by cell cycle arrest. Quantification (B) and
representative images (C) of Ki67+ cells (red) after Cre activation in transfected hepatocytes (YFP+, green) in cTKO;RosaLSL-YFPmice. Nuclei are visualized by DNA
staining (DAPI, blue). *p < 0.05; n.s., not significant.
(D and E) Quantification of single (yellow arrow) and adjacent (white arrows) YFP+ (red) hepatocytes in transposon-CreER-injected RosaLSL-YFP (control) or
cTKO;RosaLSL-YFP (TKO) mice at different time points after Tam. Cell membranes are visualized by immunostaining for b-catenin (green). Significances are shown
between control and TKO cells 1 week after Tam. *p < 0.05; **p < 0.01.
(F) Representative example of enlarged nuclei (DAPI, blue) in TKO hepatocytes (GFP+, green) in transposon-CreER-injected cTKO;RosamTmG mice.
Data in (B) and (E) are presented as mean ± SD.RESULTS
Acute Loss of the Rb Family Results in Transient
Proliferation in Mature Hepatocytes
To delete Rb family genes in mature hepatocytes, we con-
structed a Sleeping Beauty transposon that harbors a tamoxifen
(Tam)-inducible Cre recombinase (CreER) under the control of
a hepatocyte-specific promoter (Figure 1A). This transposon
stably integrates into a low percentage of liver cells following372 Cell Reports 8, 371–381, July 24, 2014 ª2014 The Authorshydrodynamic tail vein injection. We transfected Rb family con-
ditional triple-knockout hepatocytes (cTKO, Rblox/lox;p130lox/lox;
p107/) with this transposon-CreER vector. After 2 weeks of
recovery, mice were injected with Tam and triple-knockout
(TKO) hepatocytes were tracked using a Cre-inducible fluores-
cent reporter. Deletion of Rb family genes initially resulted in
cell cycle entry, but TKO hepatocytes rapidly and stably exited
the cell cycle (Figures 1B and 1C). cTKO hepatocytes remained
quiescent after Tam injection (YFP cells in Figure 1C).
We developed three other systems to delete the Rb gene fam-
ily in adult hepatocytes: intrasplenic injections of Ad-CMV-Cre
(Ad-Cre) in cTKO mice and Tam injections in Rosa26CreER/+
cTKO mice or AlbCreERT2/+ cTKO mice. Figure S1A summarizes
the advantages and limitations of the four approaches. Impor-
tantly, cell cycle re-entry (7–10 days after Cre induction) and
exit (2–4 weeks after Cre induction) were similarly observed
in all systems tested (Figures S1B–S1E and data not shown),
indicating that these phenotypes are independent of the
approach used to delete Rb family genes.
Strikingly, less than one-third of TKO hepatocytes underwent
one or two cell divisions (Figures 1D and 1E). In all the systems
used, a number of TKO hepatocytes had abnormally high
ploidy (Figures 1F and S1F and data not shown). We did not
observe apoptotic cell death (data not shown). These experi-
ments indicate that, in response to loss of Rb family function,
adult hepatocytes divide once or twice and/or undergo endor-
eduplication, as has been shown for Rb-only mutant hepato-
cytes (Mayhew et al., 2005) and is commonly observed in
wild-type hepatocytes (Duncan, 2013). Thus, the Rb family is
required to maintain the cell cycle arrest of adult hepatocytes,
but loss of Rb family function is not sufficient for their pro-
longed proliferation.
The Cell Cycle Arrest in Rb Family Mutant Hepatocytes
Is Independent of the p53 Pathway
The Rb/E2F and p53 pathways intersect at many levels,
including shared targets between E2F and p53, such as the
p21Cdkn1a and E2F7 cell cycle inhibitors (Aksoy et al., 2012;
Hiyama et al., 1998). Activation of the p53 pathway can serve
as a tumor-suppressive mechanism in Rb-deficient cells,
including in the liver (McClendon et al., 2011; Symonds et al.,
1994).We examined the expression of E2F targets andmembers
of the p53 pathway when TKO hepatocytes are exiting the cell
cycle 10 days after Cre induction. As expected, loss of Rb
family function led to increased expression of cell cycle genes
(Figure 2A and data not shown). We also observed induction
of a number of cell cycle inhibitors, including high levels of
p21Cdkn1a as well as other known p53 targets (Figures 2A and
S2A and data not shown).
To test whether activation of p53 and/or p21 may be in part
responsible for the cell cycle exit in TKO hepatocytes, we
crossed cTKO mice to p53lox/lox mice or p21/ mice (and
to RosamTmG/+ reporter mice). In both cases, the kinetics of
cell cycle re-entry were similar in quadruple-mutant mice
compared to TKO mice (Figures 2B and 2C). We also observed
cell cycle exit in quadruple-mutant hepatocytes 2 weeks
after Cre (Figures 2D and 2E), despite efficient deletion of
p53 (Figure S2B). We detected slightly elevated mRNA levels
of the cell cycle inhibitor p19Arf in both TKO and TKO;p21/
mutant livers compared to controls (Figures 2A and S2C)
and generated cTKO;p19Arf/ mice to investigate p53/p21-
independent functions of p19Arf. However, loss of p19Arf did
not prevent cell cycle exit (Figures 2G). Similarly, pentuple-
mutant hepatocytes in cTKO;p21/;p19Arf/ mice still exited
the cell cycle (Figure 2H). Therefore, the cell cycle arrest in
Rb family mutant hepatocytes is independent of the p19Arf/
p53/p21 module.The Cell Cycle Arrest in Rb Family Mutant Hepatocytes
Correlates with an Inhibition of E2F Transcriptional
Activity
To gain insight into the mechanisms underlying the cell cycle exit
in TKO hepatocytes, we extracted RNA and proteins from adult
cTKO livers (quiescent controls), cTKO liver 36 hr after partial
hepatectomy or 48 hr after treatment with CCl4 (both conditions
induce wild-type hepatocytes to cycle), cTKO;AlbCreERT2/+ mice
1 week after Tam (TKO cycling), and cTKO;AlbCreERT2/+ mice
2 weeks after Tam (TKO arrested). As expected, Rb/E2F cell
cycle targets were expressed at low levels in quiescent control
livers and at higher levels in cycling cells. These genes were
also downregulated in arrested TKO hepatocytes (Figures 3A,
3B, and 3C), which was confirmed in an RNA sequencing
(RNA-seq) analysis on two samples from each of the four groups
(Figures 3D, 3E, and S3A; Table S1). These data suggested that
mechanisms exist in adult hepatocytes to inhibit the prolonged
transcription of E2F target genes even in absence of the Rb
family.
Arrested Rb Family Mutant Hepatocytes Display Low
YAP/TEAD Levels and Activity
We reasoned that the mechanism enforcing cell cycle exit in
TKO hepatocytes may exist in both wild-type and mutant livers
but may be even more active in the TKO context to counteract
the propensity of the mutant cells to divide. Thus, we sought
to identify transcription factors that may regulate the genes
whose expression is specifically altered in arrested TKO cells
compared to quiescent wild-type cells. A computational analysis
of the RNA-seq data identified candidates with known roles in
proliferation and tumorigenesis (Figure S3B; Tables S2 and
S3), including enrichment for TEF1 binding sites in genes down-
regulated in arrested TKO cells. TEF1/TEAD1 is a major partner
of the transcriptional coactivators YAP and TAZ downstream
of Hippo signaling, one of the key regulators of hepatic growth,
liver size control, and liver cancer (Dong et al., 2007; Lu et al.,
2010; Zender et al., 2005). Hippo/YAP signaling has also
been shown to regulate Wnt pathway activity, another pathway
highly enriched in the analysis that plays a central role in
liver biology (Rosenbluh et al., 2012). Gene set enrichment
analysis (GSEA) showed a strong enrichment for hepatic YAP
targets (Dong et al., 2007) in genes significantly downregulated
in arrested TKO livers (Figure 4A), which was confirmed by
RT-PCR analysis of knownYAP targets (Figure 4B). Furthermore,
we observed increased YAP phosphorylation as well as reduced
YAP and TEAD1 protein levels in arrested TKO livers (Figures 4C
and S4A) suggestive of an active downregulation of YAP and
TEAD1 in TKO arrested cells.
Based on these observations, we wondered whether E2F and
YAP may regulate similar sets of genes. We used two inde-
pendent studieswhere YAP targets were defined in gene expres-
sion profiling analyses (Dong et al., 2007; Zhao et al., 2007). For
each study, we performed an enrichment analysis using tran-
scription factor target sites identified by ENCODE chromatin
immunoprecipitation sequencing (ChIP-seq) experiments (Auer-
bach et al., 2013). In both cases, we found a strong enrichment
for E2F binding in YAP targets, with the vast majority of YAP tar-
gets being also bound by E2F (Table S4; Figure S4C). ChIP-PCRCell Reports 8, 371–381, July 24, 2014 ª2014 The Authors 373
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Figure 2. The Cell Cycle Arrest in Rb Family Mutant Hepatocytes Is Independent of the Arf/p53/p21 Axis
(A) RT-PCR analysis of E2F and p53 target genes in control and TKO livers 10 days after Cre activation in cTKO;RosaCreER mice (n R 3) (n.s., not significant;
*p < 0.05, paired t test).
(legend continued on next page)
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assays confirmed binding of YAP to Mcm3 and Mcm6, two
canonical E2F targets (Figure S4D). Together, these experiments
suggested that decreased YAP/TEAD1 levels and transcriptional
activity may affect the long-term expression of key cell cycle
E2F targets (Table S5).
YAP was detectable by immunostaining in the nucleus of
cycling wild-type and TKO hepatocytes and absent in arrested
wild-type and TKO cells (Figure 4D). We recently reported
that loss of Rb family function in liver progenitor cells drives
these cells out of quiescence and leads to the development of
hepatocellular carcinoma (Figure S4E) (Viatour et al., 2011).
Cycling TKO progenitors also displayed nuclear YAP (Figure 4E),
which correlated with increased expression of YAP target genes
(Figure 4F). The expression of nuclear YAP and elevated expres-
sion of YAP target genes were conserved in TKO liver tumors
(Figures S4F and S4G). Thus, in the adult liver, hepatocyte
progenitors and hepatocytes respond differently to loss of Rb
family function and YAP/TEAD1 do not become inactivated in
progenitor populations.
Reduced Liver Size and Ectopic Activation of YAP
Are Sufficient to Revert the Cell Cycle Arrest
Observed in Rb Family Mutant Hepatocytes
These experiments revealed a striking correlation between E2F
activity, proliferation, and YAP activity in liver cells in the hepato-
cytic lineage, which led us to test the hypothesis that downregu-
lation of YAP/TEAD activity in TKO hepatocytes was limiting for
proliferation. YAP activity has been linked to the regulation of
organ size (reviewed in Avruch et al., 2011). To test if changes
in liver size may affect the proliferation of TKO hepatocytes, we
performed partial hepatectomy (PH) assays. PH was associated
with nuclear translocation of endogenous YAP, expression of
E2F targets such as MCM6, and proliferation in both quiescent
wild-type and arrested TKO hepatocytes (Figures 5A–5C, and
S5A). Remarkably, once the livers reached their normal size
5 days after PH, YAP molecules were again excluded from the
nucleus (Figure S5B) and TKO hepatocytes re-exited the cell
cycle (Figures 5D). Thus, the cell cycle potential of both wild-
type and TKO hepatocytes is under the control of the signals
involved in PH response.
To directly test if low YAP activity was a limiting factor specif-
ically in TKO hepatocytes, we transfected hepatocytes with
transposon vectors expressing wild-type or constitutively active
forms of YAP in which phosphorylation sites are mutated to
inhibit YAP nuclear exclusion and degradation (YAPS127A,
YAP3SA, or YAP5SA) (Dong et al., 2007). Wild-type YAP and
the partially active S127A mutant were primarily cytoplasmic in
both control and TKO cells, which correlated with low cell cycle
activity (Figures 5E and 5F). Strong activation of YAP has been
shown to force hepatocytes out of quiescence (Dong et al.,
2007; Lu et al., 2010; Zhou et al., 2009). Accordingly, expression(B) Quantification of cell cycle entry in triple- and quadruple-knockout hepatocyt
significant).
(C) Quantification of cell proliferation in triple- and quadruple-knockout hepatocy
Data in (A)–(C) are presented as mean ± SD.
(D–G) Immunofluorescence analysis of Ki67 (red) expression in mutant (GFP+, gre
injected mice.of the nuclear YAP5SA mutant led to proliferation of both control
and TKO hepatocytes (Figure 5E). We also observed the recruit-
ment of immune cells around the transfected cells with this YAP
isoform and the elimination of the transfected cells after a few
weeks, although the basis for this observation remains unclear
(data not shown). Importantly, expression of YAP3SA, a form
of YAP with presumed intermediate potency, led to a higher
cell cycle activity specifically in TKO cells compared to control
cells (Figures 5E and 5F). Additionally, the E2F target MCM6
was significantly expressed only in TKO cells transfected with
YAP3SA and not in TKO cells with a control transposon or
wild-type hepatocytes transfected with YAP3SA (Figures 5G
and S5C). Thus, Rb family mutant hepatocytes are more sensi-
tive to YAP activation than control hepatocytes, indicating that
YAP activity is a key limiting factor in the capacity of TKO hepa-
tocytes to proliferate.
DISCUSSION
Experiments in the past three decades have identified the Rb/
E2F pathway as an essential regulator of a cell’s decision to enter
or exit the cell cycle. Here, we show that even in the absence of
the Rb family, hepatocytes in the liver of adult mice possess a
mechanism that can enforce quiescence in vivo.
Loss of Rb family function in adult stem/progenitor cells often
results in the development of preneoplastic or neoplastic growth,
as was shown for example in the hematopoietic system (Viatour
et al., 2008), the mammary gland (Jiang et al., 2010), and the
liver (Viatour et al., 2011). In postmitotic differentiated cells,
loss of the Rb family has either no effect or often leads to cell
death, which can be triggered by p53 (Symonds et al., 1994;
Viatour et al., 2008). Loss of Rb family function can also lead
to dedifferentiation, proliferation, and tumor formation (Ajioka
et al., 2007) or to prolonged noncancerous growth (Garfin
et al., 2013). In hepatocytes, however, the transient proliferative
state triggered by inactivation of the Rb family is followed by a
stable cell cycle arrest. Together, these observations indicate
that the Rb family is a primary regulator of the cell cycle in
stem/progenitor cell populations. In contrast, additional mecha-
nisms may regulate the cell cycle of differentiated cells, even
within the same organ or tissue.
The cell cycle entry observed in TKO hepatocytes occurs in
the context of a liver of normal size. We propose that this initial
proliferative phase, which is associated with an increase in liver
size (Figure S5D), triggers a compensatory mechanism con-
nected to organ size sensing in the liver, instructing TKO hepato-
cytes to stop cycling. At the molecular level, loss of Rb family
function initially results in activation of E2F and transcription of
cell cycle genes. As this ectopic proliferative phase takes place,
compensatory signals eventually lead to the downregulation of
YAP/TEAD transcriptional activity, in part through cytoplasmices 1 week after induction of Cre in transposon-CreER-injected mice. (n.s., not
tes 10 days after Cre induction (n.s., not significant; *p < 0.05; **p < 0.01).
en) hepatocytes 2 weeks after Cre induction in the liver of transposon-CreER-
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(D) CummeRbund heatmap showing differential expression of curated canonical E2F target genes in cycling and noncycling TKO and control livers (RNA-seq;
n = 2).
(E) Gene set enrichment analysis of genes significantly downregulated in arrested versus cycling TKO livers using a gene set generated from top E2F targets
(Xu et al., 2007).relocalization of YAP. While low YAP levels suggest that kinases
in the Hippo pathway may be involved in this response, the
lower levels of TEAD, which is not currently known to be regu-
lated by phosphorylation, suggest that additional mechanisms
may be at play. One intriguing possibility would be if inhibitors
of YAP and TEAD were E2F targets, creating a negative feed-
back loop. The molecular basis for the differential response to376 Cell Reports 8, 371–381, July 24, 2014 ª2014 The Authorsloss of the Rb family in progenitors andmature liver cells remains
unknown.
YAP/TEAD complexes bind to many key cell cycle genes, and
we propose that the long-term transcription of these E2F targets
requires YAP/TEAD as cofactors. In support of this idea, evi-
dence in Drosophila has linked E2F and YAP activity at the pro-
moter of target genes. For instance, E2F activity is important for
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Figure 5. YAP Activation Is Sufficient to Revert the Cell Cycle Arrest in TKO Livers
(A–C) Immunofluorescence analysis of YFP (green) together with endogenous YAP (A), MCM6 (B), or Ki67 (C), respectively, after two-third partial hepatectomy
(PH), 2 weeks after Tam in CreER transposon-injected cTKO;RosaLSL-YFP mice.
(D) Immunofluorescence staining of GFP (green) and Ki67 (red) 5 days after two-third PH, 2 weeks after Tam in CreER transposon-injected cTKO;RosamTmG
mice.
(E) Immunofluorescence analysis of YAP (Flag, green) and Ki67 (red) following hydrodynamic tail vein injection of a transposon expressing either wild-type YAP
or constitutively active variants of YAP (YAPS127A, YAP3SA, or YAP5SA) into control or arrested TKO livers (transposon injection 1 week after 50 mg Tam, livers
analyzed 2 weeks after Tam).
(legend continued on next page)
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the proliferation of Hippo mutant cells in flies, and the concomi-
tant loss of Rb and Hippo signaling leads to proliferation and
dedifferentiation in flies (Nicolay et al., 2010, 2011). Finally,
consensus E2F binding sites are enriched close to YAP binding
sites in fly cells (Oh et al., 2013) and human cells (this work and
Kapoor et al., 2014; Shao et al., 2014). Thus, a decrease in tran-
scriptional YAP activity in response to the ectopic proliferation
induced by loss of Rb family function might prevent the acti-
vation of cell cycle genes despite initial high E2F activity in
TKO hepatocytes. The molecular basis of the functional interac-
tion between E2F and YAP/TEADmay include direct interactions
between transcriptional complexes containing these transcrip-
tion factors at promoters. In addition, our experiments do not
rule out the possibility that other proproliferative factors may
be limiting in TKO cells exiting the cell cycle or may be cooperat-
ing with low YAP activity. In particular, we found that Myc levels,
but not levels of other putative oncogenes such as activated ERK
or AKT, rapidly decreased in TKO hepatocytes entering quies-
cence (Figure S4B and data not shown). Future experiments
will further dissect the regulatory networks implicated in cell
cycle decisions in adult hepatocytes.
Recent experiments in mammalian cells indicate that low
levels of the LATS2 kinase in the Hippo pathway may weaken
the ability of Rb to induce cell cycle arrest in tumor cells (Tscho¨p
et al., 2011). Furthermore, in breast cancer, loss of RB may
replace amplification of YAP, further connecting these two path-
ways (Cheng et al., 2010). The dominant effect of organ size
control mechanisms and YAP activity in cells with abrogation
of the G1/S checkpoint identifies a hierarchy in the regulation
of the cell cycle andmay have important consequences in regen-
erative medicine and the development of anticancer strategies.
EXPERIMENTAL PROCEDURES
Mice
Rb family cTKOmice (Viatour et al., 2011) weremaintained in amixed 129Sv/J;
C57/BL6 background. p53lox/lox and p19Arf/mice were generous gifts of Drs.
Anton Berns and Chuck Sherr, respectively. p21/, Rosa26LSL-YFP, and
Rosa26mTmG mice were purchased from The Jackson Laboratory. For Ad-Cre
injections, 10- to 12-week-old mice were anesthetized and surgically opened
on the upper left quadrant of the abdomen, followed by injection of adenovirus
into the spleen. In cTKO;RosaCreERT2/+ mice, Cre was induced by three
consecutive injections of 1 mg Tam (T-5648; Sigma-Aldrich). In cTKO;
AlbCreERT2/+ mice (a kind gift of Pierre Chambon) (Schuler et al., 2004), Cre
was activated by injection of 20 mg to 1 mg Tam. CreER was cloned in the
transposon vector (Yant et al., 2000) from the MB80 plasmid (Addgene
#12168); YAP, YAPS127A, and YAP5SA were cloned from Addgene plasmids
#19045, #17794, and #27371, respectively. YAP3SA (S61A, S109A, S127A) is
a swap mutant of YAP and YAP5SA. Samples were 36 hr (for RNA and protein
analysis) or 48 hr (for immunostaining and ChIP experiments) after PH. All
experiments with mice were approved by the Stanford Institutional Animal
Care and Use Committee.
Histology, Immunostaining, and Immunoblot Analysis
Antigen retrieval on paraffin sections was performed using Trilogy (Cell
Marque). After blocking, sections were incubated with primary antibodies(F) Quantification of Ki67-positive YAP-transfected hepatocytes. Data are presen
(G) Quantification of MCM6-positive hepatocytes following YAP3SA expression i
livers analyzed 2 weeks after Tam). Controls, Flag-negative cells in control livers;
control livers; YAP3SA TKO, Flag-positive cells in arrested TKO livers. Data are povernight at 4C, washed in PBS plus 0.1% Tween 20, and then incubated
with secondary antibodies. Quantification was performed using ImageJ
software. Primary antibodies used were anti-GFP (Invitrogen), anti-Ki67 (BD
Pharmingen), anti-Flag (Sigma), anti-bromodeoxyuridine (BD Pharmingen),
anti-YAP, anti-PH3, anti-CC3 (Cell Signaling Technology; data not shown),
anti-MCM6, and anti-p21 (Santa Cruz Biotechnology). For immunoblotting,
primary antibodies used were anti-YAP, anti-P-ERK, anti-ERK (Cell Signaling),
anti-TEF1 (BD Biosciences), anti-p21, anti-E2F1, anti-Cyclin A, anti-PCNA,
anti-MCM6 (Santa Cruz Biotechnology), and anti-Cyclin E (eBiosciences).
Flow Cytometry
Hepatic nuclei were isolated from frozen liver tissue (Mayhew et al., 2005), and
ploidy was analyzed by flow cytometry using staining for propidium iodide.
RT-PCR, RNA-Seq, and Bioinformatics Analysis
RNAs were processed and quantitative PCR reactions were prepared as
previously described (Viatour et al., 2011). RNA-seq, TopHat, and Cufflinks
analysis were performed by Centrillion Biosciences. CummeRbund was
used for heatmap visualization and clustering of RNA-seq data. E2F1/YAP
cotarget genes were defined as genes with a significant ChIP-seq peak
for E2F1 (ENCODE data) with direct overlap or within ±2.5 kb from the tran-
scription site of YAP-regulated genes (Dong et al., 2007; Zhao et al., 2007).
Curated gene sets for GSEA (version 3.1) (Subramanian et al., 2005)
were obtained from http://www.broadinstitute.org/gsea/msigdb/index.jsp.
Enrichment was considered significant when the p value was <0.05 and
the FDR was <0.25. Gene Ontology analysis was performed using DAVID
(GOTERM_BP_FAT, DAVID Bioinformatics Resources 6.7) and transcription
factor target analysis using WebGestalt Gene Set Analysis Toolkit V2 (Zhang
et al., 2005).
ChIP Analysis
ChIP was performed as described previously (O’Geen et al., 2006). In brief,
mouse livers were perfused 5 min with 2% formaldehyde, before homogeni-
zation with a Potter-Elvehjem tissue grinder, followed by 10 min crosslinking
in 2% formaldehyde. Antibodies used for immunoprecipitation were YAP
(Cell Signaling) and p16 (sc-467). Promoter binding was assessed by quantita-
tive PCR using SYBR green (Quanta Biosciences).
Statistical Analysis
Statistical significance was assayed by two-tailed Student’s t test (*p < 0.05;
**p < 0.01;***p < 0.005). Data are presented as mean ± SD if not stated
otherwise.
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